Europe — EMA

Paliperidona Teva (Paliperidone)

Paliperidone, the active ingredient in Paliperidona Teva, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and schizoaffective disorder in adults.

Paliperidone

Request sourcing

Pack/s

What is Paliperidone?

Paliperidone, the active ingredient in Paliperidona Teva, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and schizoaffective disorder in adults. GNH USA supplies Paliperidona Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Paliperidona Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Paliperidone used for?

Paliperidone acts on the dopamine and serotonin pathways in psychiatric disorders. - Schizophrenia: Improves psychotic symptoms and reduces relapse risk. - Schizoaffective disorder: Stabilises mood and psychotic features. - Maintenance treatment of schizophrenia: Helps maintain symptom control over the long term.

What are the side effects of Paliperidone?

Paliperidone may elicit a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Ak Ak "); - "); - ");\n- ... ... ... ... - ... - ");

Serious or Rare ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →